Phase II Study of Imatinib Mesylate in Patients with Prostate Cancer with Evidence of Biochemical Relapse After Definitive Radical Retropubic Prostatectomy or Radiotherapy

Gopal K. Bajaj, Zhe Zhang, Elizabeth Garrett-Mayer, Renee Drew, Victoria Sinibaldi, Roberto Pili, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Theodore L. DeWeese

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Study of Imatinib Mesylate in Patients with Prostate Cancer with Evidence of Biochemical Relapse After Definitive Radical Retropubic Prostatectomy or Radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences